30-Day Tirzepatide ODT Weight Management Program
The 30-Day Tirzepatide ODT Weight Management Program is designed for eligible adults seeking physician-guided medical weight management through Newfield Health’s secure telehealth platform.
This program uses a compounded Tirzepatide orally disintegrating tablet formulation. Before treatment is prescribed, a licensed healthcare provider reviews your medical history, current medications, allergies, gastrointestinal history, pregnancy status, treatment goals, and overall clinical profile to determine whether this formulation is appropriate.
Program Includes
- 30-day prescription treatment program
- Compounded Tirzepatide orally disintegrating tablets
- Confidential online medical assessment
- Licensed healthcare provider evaluation
- Prescription transmitted to a licensed compounding pharmacy if approved
- Provider-guided treatment monitoring and follow-up
How It Works
- Complete your secure online medical assessment.
- A licensed healthcare provider reviews your health history, current medications, allergies, treatment goals, and relevant clinical factors.
- If Tirzepatide ODT is clinically appropriate, a prescription is sent to a licensed compounding pharmacy.
- The pharmacy prepares and fulfills the prescribed treatment.
Who May Be Considered
This program may be considered for eligible adults seeking medically supervised weight management. Suitability depends on your medical history, current medications, gastrointestinal health, pregnancy status, treatment goals, and individual clinical needs.
Important Safety Information
Prescription medications are not appropriate for everyone. Your healthcare provider evaluates your medical history, allergies, current medications, pregnancy status, gastrointestinal history, and other relevant clinical factors before prescribing treatment.
Potential side effects may include nausea, vomiting, diarrhea, constipation, abdominal discomfort, reduced appetite, fatigue, dizziness, or other individual reactions. Contact your healthcare provider if you experience persistent, severe, or concerning symptoms.
Compounded Medication Notice
This program uses a compounded Tirzepatide orally disintegrating tablet formulation prepared by a licensed compounding pharmacy. Compounded medications are not FDA-approved. A licensed healthcare provider determines whether the compounded formulation is clinically appropriate based on your individual healthcare needs.
Prescription Required
Enrollment or purchase does not guarantee that a prescription will be issued. All prescribing decisions are made independently by a licensed healthcare provider following a complete clinical review.
